[1] WANG L,BYRUM B,ZHANG Y.New variant of porcine epidemic diarrhea virus,United States,2014[J].Emerging Infectious Diseases,2014,20(5):917-919.
[2] CHUNG H C,NGUYEN V G,MOON H J,et al.Isolation of porcine epidemic diarrhea virus during outbreaks in south Korea,2013-2014[J].Emerging Infectious Diseases,2015,21(12):2238-2240.
[3] ZHAO X,LI Z,ZENG X,et al.Sequence analysis of the spike gene of porcine epidemic diarrhea virus isolated from South China during 2011-2015[J].Journal of Veterinary Science,2017,18(2):237-243.
[4] LANGEL S N,PAIM F C,LAGER K M,et al.Lactogenic immunity and vaccines for porcine epidemic diarrhea virus (PEDV):Historical and current concepts[J].Virus Research,2016,226:93-107.
[5] SONG D,CHEN Y,PENG Q,et al.Full-length genome sequence of a variant porcine epidemic diarrhea virus strain,CH/GDZQ/2014,responsible for a severe outbreak of diarrhea in piglets in Guangdong,China,2014[J].Genome Announcements,2014,2(6):e01239-14.
[6] DIEP N V,NORIMINE J,SUEYOSHI M,et al.Novel porcine epidemic diarrhea virus (PEDV) variants with large deletions in the spike (S) gene coexist with PEDV strains possessing an intact S gene in domestic pigs in Japan:A new disease situation[J].PLoS One,2017,12(1):e0170126.
[7] DE HAAN C A,HAIJEMA B J,SCHELLEN P,et al.Cleavage of group 1 coronavirus spike proteins:How furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation[J].Journal of Virology,2008,82(12):6078-6083.
[8] LIU C,TANG J,MA Y,et al.Receptor usage and cell entry of porcine epidemic diarrhea coronavirus[J].Journal of Virology,2015,89(11):6121-6125.
[9] DENG F,YE G,LIU Q,et al.Identification and comparison of receptor binding characteristics of the spike protein of two porcine epidemic diarrhea virus strains[J].Viruses,2016,8(3):55.
[10] LI W,VAN KUPPEVELD F J,HE Q,et al.Cellular entry of the porcine epidemic diarrhea virus[J].Virus Research,2016,226:117-127.
[11] GERDTS V,ZAKHARTCHOUK A.Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses[J].Veterinary Microbiology,2017,206:45-51.
[12] ZHAO P,WANG B,JI C M,et al.Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies[J].Antiviral Research,2018,150:1-8.
[13] LI Q,XU Z,WU T,et al.A flagellin-adjuvanted PED subunit vaccine improved protective efficiency against PEDV variant challenge in pigs[J].Vaccine,2018,36(29):4228-4235.
[14] TUN H M,CAI Z,KHAFIPOUR E.Monitoring survivability and infectivity of porcine epidemic diarrhea virus (PEDV) in the infected on-farm earthen manure storages (EMS)[J].Front Microbiology,2016,7:265.
[15] BEALL A,YOUNT B,LIN C M,et al.Characterization of a pathogenic full-length cDNA clone and transmission model for porcine epidemic diarrhea virus strain PC22A[J].MBio,2016,7(1):e01451-15.
[16] WANG X N,WANG L,ZHENG D Z,et al.Oral immunization with a Lactobacillus casei-based anti-porcine epidemic diarrhoea virus (PEDV) vaccine expressing microfold cell-targeting peptide Co1 fused with the COE antigen of PEDV[J].Journal of Appllied Microbiology,2018,124(2):368-378.
[17] KIM S H,CHO B H,LEE K Y,et al.N-terminal domain of the spike protein of porcine epidemic diarrhea virus as a new candidate molecule for a mucosal vaccine[J].Immune Network,2018,18(3):e21.
[18] ZHAO P D,TAN C,DONG Y,et al.Genetic variation analyses of porcine epidemic diarrhea virus isolated in mid-eastern China from 2011 to 2013[J].Canadian Journal Veterinary Research,2015,79(1):8-15.
[19] WANG X Y,JI C J,ZHANG X,et al.Infection,genetic and virulence characteristics of porcine epidemic diarrhea virus in northwest China[J].Infection Genetics and Evolution,2018,11(1):34-39.
[20] PREMANAND B,ZHONG WEE P,PRABAKARAN M.Baculovirus surface display of immunogenic proteins for vaccine development[J].Viruses,2018,10(6):E298.
[21] WANG W,CHEN X,XUE C,et al.Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein[J].Vaccine,2012,30(49):7072-7077.
[22] ROLDAO A,MELLADO M C,CASTILHO L R,et al.Virus-like particles in vaccine development[J].Expert Review Vaccines,2010,9(10):1149-1176.
[23] CHI J N,WU C Y,CHIEN M S,et al.The preparation of porcine circovirus type 2(PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development[J].Journal of Biotechnology,2014,181(3):12-19.
[24] GE J,AN Q,SONG S,et al.Construction of recombinant baculoviruses expressing infectious bursal disease virus main protective antigen and their immune effects on chickens[J].PLoS One,2015,10(7):e0132993.
[25] QI J,LIU T,LI Z,et al.Expression of limulus factor C in silkworm larvae by Bac-to-Bac/BmNPV baculovirus expression system[J].Sheng Wu Gong Cheng Xue Bao,2014,30(10):1594-1601.
[26] LIU Z,LIU Y,ZHANG Y,et al.Surface displaying of swine IgG1 Fc enhances baculovirus-vectored vaccine efficacy by facilitating viral complement escape and mammalian cell transduction[J].Veterinary Research,2017,48(1):29.
[27] HE Y,LI J,HECK S,et al.Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein:Implication for vaccine design[J].Jounal of Virology,2006,80(12):5757-5767.
[28] LI C,LI W,LUCIO DE ESESARTE E,et al.Cell attachment domains of the porcine epidemic diarrhea virus spike protein are key targets of neutralizing antibodies[J].Jounal of Virology,2017,91(12):e00273-17.
[29] OKDA F A,LAWSON S,SINGREY A,et al.The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing epitopes[J].Virology,2017,509:185-194. |